1. 4 insights on increasing anesthesia use in outpatient GI procedures
Click here
2. UCLA researchers identify risk factors for tainted scopes’ bacteria transmission — 5 points
Click here
3. Revenue per GI/endoscopy case in ASCs: 18 statistics
Click here
4. AGA, other societies express concerns about alternate payment model adoption to CMS: 4 notes
Click here
5. Valeant Pharmaceuticals’ Salix to pay $54M for alleged illegal kickbacks: 6 things to know
Click here
More articles on GI/endoscopy:
Global endoscopy devices market to reach $36.5B by 2022: 6 key trends
Umecrine Cognition names Dr. Bruce Scharschmidt senior development advisor: 4 points
UCLA researchers identify risk factors for tainted scopes’ bacteria transmission — 5 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
